EUVIMEDEUVIMED entdecken
Crossref

ISPGHANCON 2023 & CAPGAN 2023

Annals of Pediatric Gastroenterology and Hepatology ISPGHAN · 2024

DOI: 10.5005/apgh-5-4-65 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Pediatric Gastroenterology and Hepatology ISPGHAN, 2024.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

October-December 2023) 68 midodrine or standard medical therapy (SMT) alone for 6 months.Oral midodrine was started at 0.25 mg/kg/day and titrated to a maximum dose of 0.5 mg/kg/day based on the increase in mean arterial pressure.

Results

A total of 35 subjects were randomized-18 into the midodrine arm and 17 in the SMT arm.All baseline parameters, including disease severity scores, were comparable in the two groups except for higher creatinine (0.35 vs 0.24 mg/dL, p = 0.045) and higher plasma renin activity (PRA) at baseline [midodrine arm: 12.4, interquartile range (IQR): 5.5-30.67ng/mL/hour; SMT arm: 6.5, IQR: 4.3-14 ng/mL/hour; p = 0.039] in midodrine arm.Patients in the midodrine arm had a lower incidence of new-onset acute kidney injury (AKI) [odds ratio (OR): 0.17, 95% confidence interval (CI): 0.03-0.997,p = 0.049] and hyponatremia (OR: 0.139, 95% CI: 0.26 -0.739, p = 0.025), as compared to patients receiving SMT.There was an increase in the estimated glomerular filtration rate at 1 and 6 months in patients in the midodrine arm.Midodrine led to a reduction of PRA at 3 and 6 months compared to baseline, while PRA increased in patients in the SMT arm.There was no difference in ascites resolution, recurrence of ascites, episodes of spontaneous bacterial peritonitis, hepatic encephalopathy, or native liver survival.

Conclusion

Midodrine lowers the incidence of new-onset AKI and hyponatremia in cirrhotic children awaiting LT by decreasing RAAS activation.

Zitieren

APA

(2024). ISPGHANCON 2023 & CAPGAN 2023. Annals of Pediatric Gastroenterology and Hepatology ISPGHAN. https://doi.org/10.5005/apgh-5-4-65

Vancouver

ISPGHANCON 2023 & CAPGAN 2023. Annals of Pediatric Gastroenterology and Hepatology ISPGHAN. 2024. doi:10.5005/apgh-5-4-65

BibTeX
@article{euvimed2024,
  title = {ISPGHANCON 2023 & CAPGAN 2023},
  journal = {Annals of Pediatric Gastroenterology and Hepatology ISPGHAN},
  year = {2024},
  doi = {10.5005/apgh-5-4-65}
}
Kostenlos starten →